📰 Vortex Biosciences News
Vortex Biosciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vortex Biosciences. Real-time updates on events, politics, business and more.
November 15, 2022
CHICAGO, Nov. 15, 2022 /PRNewswire/ -- Liquid Biopsy Market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3% according to a new report by MarketsandMarkets.
October 5, 2022
Vortex Biosciences PLCs CEO Paul Jones explains the companys technology for capturing live circulating tumour cells (CTCs). One of NetScientific PLC...
January 25, 2022
Liquid Biopsy Market worth $5.8 billion by 2026 – Emerging Trends, Top Growing Segments and Future Industry Developments
January 25, 2022
Liquid Biopsy Market worth $5.8 billion by 2026 – Emerging Trends, Top Growing Segments and Future Industry Developments
November 30, 2021
CHICAGO, Nov. 30, 2021 /PRNewswire/ -- According to the new market research report "Liquid Biopsy Market by Product (Assay Kits, Instruments, Service), Circulating Biomarkers (CTC, ctDNA), Technology
November 30, 2021
/PRNewswire/ -- According to the new market research report "Liquid Biopsy Market by Product (Assay Kits, Instruments, Service), Circulating Biomarkers (CTC,...
November 30, 2021
/PRNewswire/ -- According to the new market research report "Liquid Biopsy Market by Product (Assay Kits, Instruments, Service), Circulating Biomarkers (CTC,...
June 2, 2021
London, UK (PRWEB) June 02, 2021 -- Vortex Biosciences has developed the VTX-1, a best-in-class instrument that isolates and purifies Circulating Tumor Cells